Adding radiotherapy to first-line chemoimmunotherapy at initial diagnosis can improve patient prognosis for those with extensive-stage small cell lung cancer (SCLC), according to findings from a real-world study shared at the
Radiotherapy Plus Chemoimmunotherapy Improves Frontline ES-SCLC Prognosis
